Research article
Open Access
Open Peer Review
This article has Open Peer Review reports available.
Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment
- Juan Carlos Higareda-Almaraz1, 2,
- Juan S. Ruiz-Moreno1, 3,
- Jana Klimentova4,
- Daniela Barbieri1, 5,
- Raquel Salvador-Gallego1, 6,
- Regina Ly1,
- Ilse A. Valtierra-Gutierrez7,
- Christiane Dinsart8,
- Gabriel A. Rabinovich9,
- Jiri Stulik4,
- Frank Rösl1Email author and
- Bladimiro Rincon-Orozco1, 10Email authorView ORCID ID profile
Received: 20 January 2016
Accepted: 9 August 2016
Published: 24 August 2016
Open Peer Review reports
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 20 Jan 2016 | Submitted | Original manuscript |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Author responded | Author comments | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 9 Aug 2016 | Editorially accepted | |
| 24 Aug 2016 | Article published | 10.1186/s12885-016-2700-8 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
Authors’ Affiliations
(1)
Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany
(2)
Institute for Diabetes and Cancer, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany
(3)
Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité, Germany
(4)
Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defense, Hradec Králové, Czech Republic
(5)
Unit of Microbiology, Department of Diagnostic Medicine and Prevention, S. Orsola-Malpighi University Hospital, Bologna, Italy
(6)
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany
(7)
Department Biologie II, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany
(8)
Division of Tumor Virology, German Cancer Research Center (DKFZ), Heidelberg, Germany
(9)
Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad de Buenos Aires, Argentina
(10)
Microbiology School, Universidad Industrial de Santander, Bucaramanga, Colombia
